Controlant BioTrack is a mobile logistics app for drivers transporting temperature-sensitive biological samples across clinical trials and diagnostic labs.
Product velocity
Dormant
Daily rank 🇺🇸
—
Business
Sentiment
—
—
Nemesis
FedEx Mobile
The App DNA
What makes this app unique?
Drivers hire this app to maintain regulatory compliance and chain-of-custody documentation, which prevents costly sample spoilage and audit failures.
For Drivers and logistics personnel managing time-sensitive, temperature-controlled biological samples for clinical trials and diagnostic labs.
Key features
Drivers monitor temperature conditions of transport boxes via the mobile app during transit
Digital custody logs and QR code handovers track sample movement from pickup to lab delivery
Drivers add samples from multiple pickup locations and track route timing via the app interface
Drivers receive live notifications when temperature boundaries are breached during transport
How much does it cost?
The app functions as a free utility for authorized drivers within the broader Controlant B2B platform.
Velocity
Dormant developmentopaqueShow more...
The development momentum is classified as zombie due to the lack of updates for over a year. The most recent release occurred on May 25, 2024, and there has been no activity since that date. Given the significant gap between the last release and the current date, there is no evidence of ongoing maintenance or feature development.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Controlant BioTrack
How's the Business market?
BioTrack functions as a specialized B2B utility within the Business category, lacking the public-facing chart presence of general logistics apps.
Read the market outlookThe rivals identified
By FedEx
FedEx Mobile competes for the same logistics-heavy user base by providing end-to-end tracking and delivery management, though it operates at a massive scale compared to BioTrack's niche clinical focus.
- Massive global infrastructure and brand recognition provide a trust barrier that specialized apps cannot easily replicate.
- Advanced consumer-facing features like delivery manager and package widgets offer superior convenience for high-volume logistics users.
- Deep integration with global shipping networks creates a data flywheel that niche clinical apps lack.
Linde GasTrackerContender
Rocket DeliveryContender
Parcel TracerContender
Shipment NotificationContenderUnlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Controlant BioTrack
Where is it heading?
The clinical logistics market is consolidating around integrated digital compliance, and BioTrack's current posture is defensive. The PM must transition from a passive utility to an active driver-experience platform to prevent enterprise courier apps from capturing the clinical-trial segment.
- The app maintains a stable, specialized utility role within the Controlant B2B platform, focusing on compliance rather than consumer-facing growth.
- The absence of public-facing reviews and updates suggests a maintenance-mode posture, which limits the ability to iterate on driver-side workflow friction.
The SWOT
- Clinical-grade compliance audit logs ensure high switching costs for trial partners
- Real-time excursion alerts provide a critical safety mechanism for biological cargo
- Integration with wearable sensor hardware could expand the monitoring scope
- Expansion into broader pharmaceutical supply chain logistics could increase total addressable market
Next best moves
Audit offline-sync capabilities because current reviews suggest high-stakes data loss risk → improve reliability
The counter-intuitive read
The app's lack of public-facing ratings is not a failure but a feature…
Read the full takeFeature gaps
Integrated financial oversight tools (available in Parcel Tracer but absent here) +1
Since the last report: The report shifted from addressing facility-level intelligence gaps to prioritizing offline-sync reliability, while reorienting the competitive landscape toward enterprise courier incumbents.
Bottom line
BioTrack secures its clinical niche through specialized compliance features, but the lack of public-facing engagement and offline robustness leaves it vulnerable to enterprise courier expansion, so the PM should prioritize offline-sync to defend the core clinical workflow.
Unlock 2 critical frictions, 2 market threats and the analyst’s take.
Access the full report for freeReport last updated